Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Free Cash Flow (2016 - 2026)

Champions Oncology has reported Free Cash Flow over the past 17 years, most recently at -$1.5 million for Q1 2026.

  • Quarterly results put Free Cash Flow at -$1.5 million for Q1 2026, down 2537.1% from a year ago — trailing twelve months through Jan 2026 was $4.2 million (up 265.42% YoY), and the annual figure for FY2025 was $7.0 million, up 200.34%.
  • Free Cash Flow for Q1 2026 was -$1.5 million at Champions Oncology, down from -$1.5 million in the prior quarter.
  • Over the last five years, Free Cash Flow for CSBR hit a ceiling of $6.9 million in Q2 2025 and a floor of -$4.7 million in Q3 2023.
  • Median Free Cash Flow over the past 5 years was $62000.0 (2025), compared with a mean of $152764.7.
  • Biggest five-year swings in Free Cash Flow: soared 460.67% in 2022 and later crashed 2537.1% in 2026.
  • Champions Oncology's Free Cash Flow stood at $2.7 million in 2022, then tumbled by 80.98% to $510000.0 in 2023, then crashed by 155.49% to -$283000.0 in 2024, then plummeted by 420.14% to -$1.5 million in 2025, then fell by 2.65% to -$1.5 million in 2026.
  • The last three reported values for Free Cash Flow were -$1.5 million (Q1 2026), -$1.5 million (Q4 2025), and $314000.0 (Q3 2025) per Business Quant data.